MAPT and Alzheimer disease: In this framework, aging drives abnormal tau processing driving neurodegeneration [92,93,94] with Aβ pathology accelerating [91,93,94,95] and contributing to [90,91,95,96] this process, reconciling spatiotemporal pathological data across the aging population [8,94,97] with the causes of familial forms of AD [90].